![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
B Inhibitor, Parthenolide
Department of Molecular and Cellular Biology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan (K.T., J.H., K.A., T.O.); and Department of Research and Development, Ichimaru Pharcos Co., Ltd., Motosu, Japan (K.T.)
The skin photoaging is characterized by keratinocyte hyperproliferation and degradation of collagen fibers, causing skin wrinkling and laxity and melanocyte proliferation that leads to pigmentation. UV is considered to be a major cause of such skin changes. It is well established that nuclear factor
B (NF-
B) is activated upon UV irradiation and induces various genes including interleukin-1 (IL-1), tumor necrosis factor
(TNF
), and matrix metalloprotease-1 (MMP-1). It is also known that basic fibroblast growth factor (bFGF) production is induced by UV and promotes the proliferation of skin keratinocytes and melanocytes. We found that UVB, IL-1, and TNF
induced NF-
B activation and then produced MMP-1 and bFGF in HaCaT keratinocytes and skin fibroblasts. In this experiment, we examined if parthenolide, an NF-
B inhibitor, could block the UVB-mediated skin changes. We found that parthenolide could effectively inhibit the gene expression mediated by NF-
B and the production of bFGF and MMP-1 from cells overexpressing p65, a major subunit of NF-
B. We also found that parthenolide could inhibit the UVB-induced proliferation of keratinocytes and melanocytes in the mouse skin. These findings suggest that NF-
B inhibitors should be useful for the prevention of skin photoaging.
Address correspondence to: Dr. Takashi Okamoto, Department of Molecular and Cellular Biology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan. E-mail: tokamoto{at}med.nagoya-cu.ac.jp
This article has been cited by other articles:
![]() |
H.-R. Kim, M.-L. Cho, K.-W. Kim, J.-Y. Juhn, S.-Y. Hwang, C.-H. Yoon, S.-H. Park, S.-H. Lee, and H.-Y. Kim Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-{kappa}B- and p38 MAPK-dependent signalling pathways Rheumatology, January 1, 2007; 46(1): 57 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Lopez-Franco, P. Hernandez-Vargas, G. Ortiz-Munoz, G. Sanjuan, Y. Suzuki, L. Ortega, J. Blanco, J. Egido, and C. Gomez-Guerrero Parthenolide Modulates the NF-{kappa}B-Mediated Inflammatory Responses in Experimental Atherosclerosis Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1864 - 1870. [Abstract] [Full Text] [PDF] |
||||